TG Therapeutics, a biopharmaceutical company, develops agents for the treatment of hematologic malignancies and autoimmune disorders. read more

EMPLOYEE PARTICIPANTS: 16

TOTAL RATINGS: 235

CEO: Michael Weiss

TG Therapeutics Executive Team

The TG Therapeutics Executive Team is rated a "D" and led by CEO Michael Weiss. TG Therapeutics employees rate their Executive Team in the Bottom 20% of similar size companies on Comparably with 11-50 Employees.

Out of their 3 competitors, Biogen, MyoKardia, and Reata Pharmaceuticals, TG Therapeutics' score ranks in 2nd place.

Last updated months ago.

Where This Score Ranks TG Therapeutics' Executive Team

BOTTOM
20%
In the Bottom 20% of 1950 Similar Sized Companies on Comparably
BOTTOM
25%
In the Bottom 25% of 544 Nearby Companies in New York
2nd
2nd place versus 3 competitors rated on Comparably

Feb

May

Jul

Aug

Jun

D58 / 100

Jan

TG Therapeutics Key Executives

Name & Title

Bio

Who Ranks TG Therapeutics' Executive Team the Highest?

Not Enough Ratings To Show Who Ranks Executive Team the Highest

Anonymously rate my experience at TG Therapeutics

Who Ranks TG Therapeutics' Executive Team the Lowest?

Not Enough Ratings To Show Who Ranks Executive Team the Lowest

Anonymously rate my experience at TG Therapeutics

TG Therapeutics' Executive Team Trendline

TG Therapeutics56
Other Companies in New York
Similar Size on Comparably

TG Therapeutics Executive Team At a Glance

The Executive Team Score of 58/100 is calculated by combining aggregate responses to the questions of “How would you rate your executive team?” and “Do you approve of the job your executive team is doing at your company?”

The last rating scoring TG Therapeutics' executive team was provided months ago and has remained stable at 58 over the last 90 days.